(Q33868231)

29 July 2017

1 reference

title

Chemotherapy for falciparum malaria: the armoury, the problems and the prospects (English)

1 reference

29 July 2017

Plasmodium falciparum

0 references

0 references

1 reference

Winstanley PA

1

1 reference

29 July 2017

1 April 2000

1 reference

29 July 2017

Trends in Parasitology

1 reference

29 July 2017

16

1 reference

29 July 2017

4

1 reference

29 July 2017

146-153

1 reference

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Antimalarial ocular toxicity a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Treatment of severe chloroquine poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Antimalarial drug resistance: the pace quickens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Antimalarial drug response of Plasmodium falciparum from Zaria, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Death and blindness due to overdose of quinine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Arteether administration in humans: preliminary studies of pharmacokinetics, safety and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

A trial of artemether or quinine in children with cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Artemether for severe malaria: a meta-analysis of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

X-ray crystal structure of the antimalarial agent (-)-halofantrine hydrochloride supports stereospecificity for cardiotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

On ;the efficacy of antifolate antimalarial combinations in Africa'

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Malarone-donation programme in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Preventing antimalarial drug resistance through combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

A randomized safety and tolerability trial of artesunate plus sulfadoxine--pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Enhancement of the antimalarial effect of chloroquine by chloropheniramine in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Comparative cardiac effects of halofantrine and chloroquine plus chlorpheniramine in children with acute uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Effect of chlorpheniramine on the pharmacokinetics of and response to chloroquine of Nigerian children with falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

An overview of chemotherapeutic targets for antimalarial drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901622-1

7 January 2021

10.1016/S0169-4758(99)01622-1

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10725901